Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Mind
The relationship recession is even bigger for Gen Z than we thought
News
Technology
Killer robots are here – we must finally decide whether to accept them
Leader
Technology
Quantum computer quickly mines cryptocurrency while using less energy
News
Mind
How to sparkle in conversation with strangers
Comment
Popular articles
Trending New Scientist articles
1
Fully autonomous drones have killed human soldiers for the first time
2
The relationship recession is even bigger for Gen Z than we thought
3
How to sparkle in conversation with strangers
4
New Scientist recommends a brilliant take on the evolution of birds
5
El Niño has started and the weather could get weird
6
Toy universe shows that time could be a quantum illusion
7
First working nuclear clock heralds a new era in timekeeping
8
Mysterious ‘cold blob’ in the Atlantic suggests the AMOC is weakening
9
Where do you think your ‘self’ is? Your answer is revealing
10
What is a ‘normal’ memory slowdown, and when should I worry?
